Stay updated on Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial

Sign up to get notified when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previously visible study record content and signaling restricted access to the study information. A basic 403 header and navigation appear where study details used to be.
    Difference
    22%
    Check dated 2026-09-19T22:25:10.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The study record adds an NIH funding note for 2017 and updates the document version to v3.6.6, while removing the previous v3.6.5 version.
    Difference
    0.1%
    Check dated 2026-08-29T20:19:37.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added and Revision: v3.6.4 was removed, signaling a minor update to the page's version or underlying content.
    Difference
    0.1%
    Check dated 2026-08-08T18:36:04.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    No textual changes were captured for this page in the provided data.
    Difference
    0.0%
    Check dated 2026-08-01T15:44:23.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The study record page was updated to Revision: v3.6.4, indicating a new release of the page. This update appears to be internal maintenance rather than a modification to study content.
    Difference
    0.0%
    Check dated 2026-07-25T10:44:31.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    A revision label on the study page was updated from v3.6.2 to v3.6.3, indicating an administrative update to the ClinicalTrials.gov page. It does not alter the study details, enrollment, or eligibility.
    Difference
    0.0%
    Check dated 2026-07-04T03:50:07.000Z thumbnail image

Stay in the know with updates to Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.